Browse diseases

…kade has emerged as a promising approach for functional cure of chronic hepatitis B (CHB).Objective This study aimed to evaluate the safety profile of an…

…rapeutic target and predictive biomarker for functional cure in chronic hepatitis B.Abstract IDDF2026-ABS-0371 Figure 1Abstract IDDF2026-ABS-0371 F…

…Background Chronic hepatitis B (CHB) is a major global cause of liver cancer, and metabolic dysfunction-associated steatotic liver disease (…

…n underdiagnosed cause of severe liver disease in patients with chronic hepatitis B (CHB). Variable testing practices can delay diagnosis and access to t…

…Introduction Chronic hepatitis B (CHB) remains a major cause of inflammatory liver disease worldwide. …

…vance of circulating preS1 antigen and anti-preS1 antibodies in chronic hepatitis B (CHB) is not well defined.Objective To characterise serum preS1 antig…

…hronic hepatitis B (CHB) remains a major cause of cirrhosis and hepatocellular carcinoma (HCC) worldwide, affecting over 250 million people. In the UK, …

…arded as a more feasible clinical endpoint for the treatment of chronic hepatitis B (CHB).1 In a recent study by Tseng et al, which explored the associat…

…3 4 Given the critical importance of non-invasive assessment of liver fibrosis for the clinical management of CHB,5 we evaluated the predictiv…

…001).Conclusion In an endemic population, >40% of patients with CHB have qHBsAg >1000 IU/mL. These patients are unlikely to achieve…

…titis B (CHB) is a major global health concern primarily due to hepatocellular carcinoma (HCC) development.Objective This study aimed to identify patien…

…tance and liver disease progression appears critical in CHB and CHB-MASLD .…